Cargando…
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
BACKGROUND: Cryptococcal meningitis has high mortality. Flucytosine is a key treatment but is expensive and rarely available. The anticancer agent tamoxifen has synergistic anti-cryptococcal activity with amphotericin in vitro. It is off-patent, cheap, and widely available. We performed a trial to d...
Autores principales: | Ngan, Nguyen Thi Thuy, Thanh Hoang Le, Nhat, Vi Vi, Nguyen Ngo, Van, Ninh Thi Thanh, Mai, Nguyen Thi Hoang, Van Anh, Duong, Trieu, Phan Hai, Lan, Nguyen Phu Huong, Phu, Nguyen Hoan, Chau, Nguyen Van Vinh, Lalloo, David G, Hope, William, Beardsley, Justin, White, Nicholas J, Geskus, Ronald, Thwaites, Guy E, Krysan, Damian, Tai, Luong Thi Hue, Kestelyn, Evelyne, Binh, Tran Quang, Hung, Le Quoc, Tung, Nguyen Le Nhu, Day, Jeremy N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547950/ https://www.ncbi.nlm.nih.gov/pubmed/34581270 http://dx.doi.org/10.7554/eLife.68929 |
Ejemplares similares
-
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2019) -
The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019) -
Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study
por: Van, Le Hong, et al.
Publicado: (2020) -
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018) -
Effectiveness of Continuous Endotracheal Cuff Pressure Control for the Prevention of Ventilator-Associated Respiratory Infections: An Open-Label Randomized, Controlled Trial
por: Dat, Vu Quoc, et al.
Publicado: (2021)